{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:24:35Z","timestamp":1773365075982,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,5]]},"DOI":"10.4103\/0366-6999.235114","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T12:06:43Z","timestamp":1530014803000},"page":"1520-1526","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus"],"prefix":"10.1097","volume":"131","author":[{"given":"Miao","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-Guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210129","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.4103\/0366-6999.189055","article-title":"Association study of a proliferation-inducing ligand, spermatogenesis associated 8, platelet-derived growth factor receptor-alpha, and POLB polymorphisms with systemic lupus erythematosus in Chinese Han population","volume":"129","author":"Li","year":"2016","journal-title":"Chin Med J"},{"key":"R3-2-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"R4-2-20210129","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4103\/0366-6999.213428","article-title":"Characteristics of proinflammatory cytokines and chemokines in airways of asthmatics: Relationships with disease severity and infiltration of inflammatory cells","volume":"130","author":"Yang","year":"2017","journal-title":"Chin Med J"},{"key":"R5-2-20210129","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"key":"R6-2-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-3083.1993.tb02590.x","article-title":"The detection and biological activity of human antibodies to IL-2 in normal donors","volume":"38","author":"Tiberio","year":"1993","journal-title":"Scand J Immunol"},{"key":"R8-2-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-2478(93)90098-M","article-title":"Purification of interleukin-2 antibodies from healthy individuals","volume":"36","author":"Monti","year":"1993","journal-title":"Immunol Lett"},{"key":"R9-2-20210129","first-page":"611","article-title":"Individuals infected with HIV possess antibodies against IL-2","volume":"65","author":"Bost","year":"1988","journal-title":"Immunology"},{"key":"R10-2-20210129","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1038\/ncomms13027","article-title":"Loss of immune tolerance to IL-2 in type 1 diabetes","volume":"7","author":"P\u00e9rol","year":"2016","journal-title":"Nat Commun"},{"key":"R11-2-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0008-8749(89)90360-2","article-title":"IL-2 antibody production in lupus mice","volume":"118","author":"Ishizaka","year":"1989","journal-title":"Cell Immunol"},{"key":"R12-2-20210129","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R13-2-20210129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1074-7613(03)00291-7","article-title":"Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity","volume":"19","author":"Wildbaum","year":"2003","journal-title":"Immunity"},{"key":"R14-2-20210129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"R15-2-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","article-title":"Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer","volume":"102","author":"Lokshin","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1084\/jem.160.3.738","article-title":"Antibodies to interleukin 2.Effects on immune responses in vitro and in vivo","volume":"160","author":"Granelli-Piperno","year":"1984","journal-title":"J Exp Med"},{"key":"R17-2-20210129","first-page":"1163","article-title":"Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2","volume":"7","author":"Hjelm Skog","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R18-2-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/jir.1994.14.177","article-title":"Human antibodies to recombinant interleukin-2 in patients with hypernephroma","volume":"14","author":"Atzpodien","year":"1994","journal-title":"J Interferon Res"},{"key":"R19-2-20210129","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/1097-0142(19910401)67:7<1862::AID-CNCR2820670708>3.0.CO;2-R","article-title":"The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2","volume":"67","author":"Kirchner","year":"1991","journal-title":"Cancer"},{"key":"R20-2-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4161\/mabs.27224","article-title":"Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effects","volume":"6","author":"Rojas","year":"2014","journal-title":"MAbs"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"R22-2-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12977-016-0311-8","article-title":"Insufficient natural killer cell responses against retroviruses: How to improve NK cell killing of retrovirus-infected cells","volume":"13","author":"Littwitz-Salomon","year":"2016","journal-title":"Retrovirology"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12977-015-0191-3","article-title":"Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection","volume":"12","author":"Littwitz-Salomon","year":"2015","journal-title":"Retrovirology"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.1401285","article-title":"IL-2\/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis","volume":"194","author":"Gaddipati","year":"2015","journal-title":"J Immunol"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.4049\/jimmunol.0804175","article-title":"Cutting edge: IL-2 immune complexes as a therapy for persistent virus infection","volume":"182","author":"Molloy","year":"2009","journal-title":"J Immunol"},{"key":"R26-2-20210129","first-page":"68","article-title":"Clinical features of systemic lupus erythematosus with normal serum IgG levels","volume":"27","author":"Yang","year":"2017","journal-title":"China J Modern Med"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0961203314525248","article-title":"Serum immunoglobulin G level in patients with lupus nephritis and the effect of treatment with corticosteroids and mycophenolate mofetil","volume":"23","author":"Yap","year":"2014","journal-title":"Lupus"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02678213","article-title":"Treatment-induced antibodies to interleukin-2","volume":"10","author":"Pr\u00fcmmer","year":"1997","journal-title":"Biotherapy"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.235114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:04Z","timestamp":1623959284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201807050-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":28,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.235114","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,5]]}}}